CN102038806A - 一种保肝组合物及其制备方法 - Google Patents
一种保肝组合物及其制备方法 Download PDFInfo
- Publication number
- CN102038806A CN102038806A CN 201010620385 CN201010620385A CN102038806A CN 102038806 A CN102038806 A CN 102038806A CN 201010620385 CN201010620385 CN 201010620385 CN 201010620385 A CN201010620385 A CN 201010620385A CN 102038806 A CN102038806 A CN 102038806A
- Authority
- CN
- China
- Prior art keywords
- liver
- preparation
- protects
- compositions
- hoveniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000002131 composite material Substances 0.000 title abstract 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000018417 cysteine Nutrition 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 12
- 229930182817 methionine Natural products 0.000 claims abstract description 12
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims abstract description 11
- 229960001570 ademetionine Drugs 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 210000004185 liver Anatomy 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 17
- 210000000582 semen Anatomy 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 230000001186 cumulative effect Effects 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- -1 electuary Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 208000007848 Alcoholism Diseases 0.000 abstract description 8
- 230000035622 drinking Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 3
- 206010009208 Cirrhosis alcoholic Diseases 0.000 abstract description 2
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract description 2
- 244000010000 Hovenia dulcis Species 0.000 abstract description 2
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 2
- 244000046146 Pueraria lobata Species 0.000 abstract description 2
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 abstract description 2
- 229960002433 cysteine Drugs 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 235000006109 methionine Nutrition 0.000 abstract 1
- 210000003813 thumb Anatomy 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 20
- 239000003814 drug Substances 0.000 description 17
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- 229950006238 nadide Drugs 0.000 description 9
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 6
- 241001126925 Lobata Species 0.000 description 6
- 201000007930 alcohol dependence Diseases 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 102000003929 Transaminases Human genes 0.000 description 5
- 108090000340 Transaminases Proteins 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 4
- 244000202052 Poncirus trifoliata Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 235000003969 glutathione Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 238000010172 mouse model Methods 0.000 description 3
- 230000035806 respiratory chain Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 3
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000002279 cholagogic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical class NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 230000010224 hepatic metabolism Effects 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- FYKBJIJHQDFVCI-KVQBGUIXSA-N (2S,5R,6R)-2,6-diamino-5,7-dihydroxyheptanoic acid Chemical compound N[C@H](CO)[C@H](O)CC[C@H](N)C(O)=O FYKBJIJHQDFVCI-KVQBGUIXSA-N 0.000 description 1
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 241000209514 Alismataceae Species 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 102000011195 Profilin Human genes 0.000 description 1
- 108050001408 Profilin Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 101000869664 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) FAD-dependent catabolic D-arginine dehydrogenase DauA Proteins 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940097265 cysteamine hydrochloride Drugs 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004590 drinking behavior Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000003037 histogenic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010106203853A CN102038806B (zh) | 2010-12-31 | 2010-12-31 | 一种保肝组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010106203853A CN102038806B (zh) | 2010-12-31 | 2010-12-31 | 一种保肝组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102038806A true CN102038806A (zh) | 2011-05-04 |
CN102038806B CN102038806B (zh) | 2012-07-18 |
Family
ID=43905568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010106203853A Active CN102038806B (zh) | 2010-12-31 | 2010-12-31 | 一种保肝组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102038806B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103181940A (zh) * | 2011-12-31 | 2013-07-03 | 瑞普(天津)生物药业有限公司 | 一种宠物用保肝营养美味片 |
WO2014016266A1 (en) * | 2012-07-23 | 2014-01-30 | Nestec S.A. | Kudzu and phytosterols for use in the treatment of metabolic disorders |
CN110101849A (zh) * | 2019-04-12 | 2019-08-09 | 暨南大学 | 一种酶催化解酒作用的组合物及其制备方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101293079A (zh) * | 2007-04-26 | 2008-10-29 | 赵凯 | 一种解酒、醒酒中药 |
-
2010
- 2010-12-31 CN CN2010106203853A patent/CN102038806B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101293079A (zh) * | 2007-04-26 | 2008-10-29 | 赵凯 | 一种解酒、醒酒中药 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103181940A (zh) * | 2011-12-31 | 2013-07-03 | 瑞普(天津)生物药业有限公司 | 一种宠物用保肝营养美味片 |
CN103181940B (zh) * | 2011-12-31 | 2015-01-07 | 瑞普(天津)生物药业有限公司 | 一种宠物用保肝营养美味片 |
WO2014016266A1 (en) * | 2012-07-23 | 2014-01-30 | Nestec S.A. | Kudzu and phytosterols for use in the treatment of metabolic disorders |
CN110101849A (zh) * | 2019-04-12 | 2019-08-09 | 暨南大学 | 一种酶催化解酒作用的组合物及其制备方法与应用 |
CN110101849B (zh) * | 2019-04-12 | 2023-11-10 | 暨南大学 | 一种酶催化解酒作用的组合物及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102038806B (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102038867B (zh) | 一种解酒组合物及其制备方法 | |
Eddouks et al. | Inhibition of endogenous glucose production accounts for hypoglycemic effect of Spergularia purpurea in streptozotocin mice | |
CN101965915B (zh) | 一种肉鸡饲料添加剂及其制备方法 | |
CN103734751B (zh) | 一种复合膳食纤维及其制法 | |
CN108434231A (zh) | 一种抗醉解酒的药食同源中药组合物及其制备方法 | |
CN111840363B (zh) | 一种纳豆辅助降血糖保健组合物及其制备方法和用途 | |
CN101721488B (zh) | 一种治疗肝病的药物组合物及其制备方法 | |
CN102038806B (zh) | 一种保肝组合物及其制备方法 | |
CN1618446A (zh) | 一种治疗糖尿病的药物及其制备方法 | |
Hancke et al. | Reduction of serum hepatic transaminases and CPK in sport horses with poor performance treated with a standardized Schizandra chinensis fruit extract | |
CN101264120B (zh) | 现代中药饮片、淫羊藿黄酮醇苷饮片及其制备方法 | |
CN102304166A (zh) | 丹参酮衍生物,其药物组合物及其在制药中的应用 | |
CN104474135A (zh) | 一种对化学性肝损伤具有辅助保护功能的药物组合物 | |
CN109464505B (zh) | 一种用于治疗糖尿病的中药组合物 | |
CN103301217A (zh) | 组合物及其应用、药物制剂及保健品 | |
CN106310138A (zh) | 一种预防乳猪腹泻的中药组合物及其制备方法 | |
CN1899415B (zh) | 一种治疗慢性肝病的中药复方制剂及其制备方法 | |
CN102764294A (zh) | 一种祛痰止咳组合物及其制备方法 | |
CN102389496A (zh) | 一种治疗肝炎的中药组合物及其制备方法 | |
CN102119776A (zh) | 一种陈皮提取物及其制备方法和应用 | |
CN102526484B (zh) | 一种降血糖的药物组合物 | |
CN112121074B (zh) | 一种防制猪病毒性疾病的复方植物提取物制剂及其应用 | |
CN105327115A (zh) | 一种防治ⅱ型糖尿病桑黄通泻配方及制备工艺 | |
CN110101849A (zh) | 一种酶催化解酒作用的组合物及其制备方法与应用 | |
CN105104755A (zh) | 一种复方叶下珠制剂及其在仔猪日粮上的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 100037 No. 2, building 40, Fu Cheng Road, 7, Beijing, Haidian District, 60803 Patentee after: Beijing Maidi Cody Connaught Gene Technology Co.,Ltd. Address before: 100022, Beijing, Chaoyang District, Yongan building, No. 16 East, CBD building, 7 West Side Patentee before: BEIJING ADINOVO TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240606 Address after: 311300 floor 3, No. 199, Chuangye street, Qingshanhu science and Technology City, Lin'an District, Hangzhou City, Zhejiang Province Patentee after: HANGZHOU MEDICAL BIOTECHNOLOGY LTD. Country or region after: China Address before: Room 60803, 7th Floor, Building 2, No. 40 Fucheng Road, Haidian District, Beijing, 100037 Patentee before: Beijing Maidi Cody Connaught Gene Technology Co.,Ltd. Country or region before: China |